Xenios, a Fresenius Medical Care company, is a global leader in technologies intended for Cardiac and Pulmonary failure. They develop unique and innovative solutions of modern medical issues, such as the Extracorporeal Membrane Oxygenation Machine, (ECMO), that combines both cardiac and pulmonary support on one platform, and the transformative Novalung, a device for the treatment of acute and chronic lung failure. BL Lifesciences has been a proud partner of Xenios for many years, and is proud to be one of only two Indian companies that provides ECMO machines to the entire market. You can read more about our work with ECMO machines during the Covid-19 pandemic.